Cambridge Healthtech Institute's 14th Annual Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists to hear presentations most suited to their personal interests by going back and forth among concurrent conferences. The 2019 conference includes coverage of Artificial Intelligence for Early Drug Discovery and Directed Evolution-Based Drug Discovery, plus even more short courses to choose from.

Our Chief Executive Officer, Dr Trevor Perrior and Assay Biology Group Leader, Dr Katie Chapman will be at the event.